ArticleMultiple sclerosis and related disorders2022

Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel.

Janick Weberpals et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.